Suppr超能文献

应用 Amplazter 导管封堵器 I 闭合膜周部室间隔缺损合并瘤样组织:经验教训和中期随访。

Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.

机构信息

Division of Pediatric Cardiology, Rady Children's Hospital-San Diego, San Diego, California, USA.

出版信息

Catheter Cardiovasc Interv. 2012 Nov 15;80(6):895-903. doi: 10.1002/ccd.23074. Epub 2012 Aug 20.

Abstract

OBJECTIVES

The aim of this report is to describe our experience with closure of perimembranous ventricular septal defects (PMVSD) with aneurysm using the Amplatzer Duct Occluder I (ADO I).

BACKGROUND

Atrio-ventricular block (AVB) remains the most troublesome complication of device closure of PMVSDs. Many PMVSDs are associated with an aneurysm that protrudes into the right ventricle. We believe that devices implanted entirely within the VSD aneurysm avoid the risk of AVB.

METHODS

A retrospective analysis of patients with PMVSD and aneurysm who underwent attempted ADO I device closure between 3/2004 and 8/2010 [Rady Children's Hospital-San Diego (n = 16), Mattel Children's Hospital at UCLA (n = 4), and Straub Hospital in Honolulu (n = 1)].

RESULTS

Twenty-one patients (16 male) with PMVSD and aneurysm underwent cardiac catheterization for the purpose of VSD closure using an ADO I. Nineteen patients had successful ADO I implantation with the following devices: 10/8 (n = 8), 8/6 (n = 7), 6/4 (n = 3) and 12/10 (n = 2). The procedure was aborted in 2 cases due to temporary AVB and ventricular ectopy during catheterization. One patient developed hemolysis due device malposition and had surgical device retrieval and VSD closure. One patient had new trivial tricuspid regurgitation and in 5/19 the tricuspid regurgitation improved post device closure. Transient accelerated junctional rhythm occurred within 24 hr in 4 patients and nonsustained slow ventricular tachycardia occurred in one patient. At latest follow-up (up to 6 years, median 1.9 years) 11/18 had no residual shunt, 4/18 had trivial and 3/18 small residual shunt. No AVB has been observed.

CONCLUSIONS

Percutaneous closure of PMVSD with aneurysm using the ADO I appears to have acceptable efficacy and risk. Atrio-ventricular block in up to mid-term follow up was not encountered.

摘要

目的

本报告旨在描述我们使用 Amplatzer 导管封堵器 I(ADO I)治疗膜周部室间隔缺损(PMVSD)合并瘤的经验。

背景

房室传导阻滞(AVB)仍然是 PMVSD 器械封堵最麻烦的并发症。许多 PMVSD 合并有向右侧心室突出的瘤。我们认为,完全植入 VSD 瘤内的器械可以避免 AVB 的风险。

方法

回顾性分析 2004 年 3 月至 2010 年 8 月期间在 Rady 儿童医院-圣地亚哥(n = 16)、UCLA Mattel 儿童医院(n = 4)和檀香山 Straub 医院(n = 1)接受 ADO I 尝试封堵 PMVSD 和瘤的患者。

结果

21 例 PMVSD 合并瘤患者接受了心脏导管术,目的是使用 ADO I 封堵 VSD。19 例患者成功植入 ADO I,使用的器械如下:10/8(n = 8)、8/6(n = 7)、6/4(n = 3)和 12/10(n = 2)。2 例因导管插入术中出现暂时性 AVB 和室性异位而中止手术。1 例因器械位置不当发生溶血,行手术取出器械并关闭 VSD。1 例患者出现新的轻微三尖瓣反流,在 19 例患者中,5 例患者的三尖瓣反流在器械封堵后改善。4 例患者在 24 小时内出现短暂加速交界性节律,1 例患者出现非持续缓慢室性心动过速。在最新随访时(最长 6 年,中位随访时间 1.9 年),18 例患者中 11 例无残余分流,4 例有轻微残余分流,3 例有小残余分流。未观察到 AVB。

结论

使用 ADO I 经皮封堵 PMVSD 合并瘤的疗效和风险似乎可以接受。在中期随访中未发现房室传导阻滞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验